Mend Syndrome
Description
MEND syndrome is a rare, genetic, syndromic, sterol biosynthesis disorder affecting males characterized by skin manifestations, including collodion membrane, ichthyosis, and patchy hypopigmentary lesions, associated with severe neurological involvement (e.g. intellectual disability, delayed psychomotor development, seizures, hydrocephalus, cerebellar/corpus callosum hypoplasia, Dandy-Walker malformation, hypotonia) and craniofacial dysmorphism (large anterior fontanelle, telecanthus, hypertelorism, microphthalmia, prominent nasal bridge, low-set ears, micrognathia, cleft palate). 2,3 toe syndactyly, polydactyly, and kyphosis, as well as ophthalmic, cardiac and urogenital anomalies may also be associated.
Clinical Features
Top most frequent phenotypes and symptoms related to Mend Syndrome
- Intellectual disability
- Seizures
- Global developmental delay
- Short stature
- Generalized hypotonia
- Scoliosis
- Failure to thrive
- Micrognathia
- Cleft palate
- Cataract
And another 58 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Mend Syndrome Is also known as male ebp disorder with neurologic defects, male ebp disorder with neurological defects.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Mend Syndrome Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
NGS XLID Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RPL10, RPS6KA3, SLC16A2, SLC9A6, SMC1A, KDM5C, SMS, SOX3, CDKL5, SYN1, SYP, TAF1, TIMM8A, TSPAN7, MED12, UBE2A, USP9X, ZMYM3, ZNF41, ZNF711 , (...)
View the complete list with 94 more genes
Specificity
1 %
Genes
100 % |
EBP sequencing.
By Genetic Services Laboratory University of Chicago (United States).
EBP
Specificity
100 %
Genes
100 % |
EBP deletion/duplication analysis.
By Genetic Services Laboratory University of Chicago (United States).
EBP
Specificity
100 %
Genes
100 % |
EBP.
By Institute for Human Genetics University Clinic Freiburg (Germany).
EBP
Specificity
100 %
Genes
100 % |
Skeletal Dysplasia Panel, Sequencing and Deletion/Duplication.
By ARUP Laboratories, Molecular Genetics and Genomics (United States).
RUNX2, SLC26A2, SOX9, TRIP11, SERPINH1, TRPV4, FKBP10, WDR19, P3H1, EVC2, SLC35D1, COL1A2, COMP, CRTAP, TTC21B, DLL3, WDR35, IFT80, DYNC2H1, EBP , (...)
View the complete list with 17 more genes
Specificity
3 %
Genes
100 % |
Skeletal Dysplasia Panel, Sequencing and Deletion/Duplication, Fetal.
By ARUP Laboratories, Molecular Genetics and Genomics (United States).
RUNX2, SLC26A2, SOX9, TRIP11, SERPINH1, TRPV4, FKBP10, WDR19, P3H1, EVC2, SLC35D1, COL1A2, COMP, CRTAP, TTC21B, DLL3, WDR35, IFT80, DYNC2H1, EBP , (...)
View the complete list with 17 more genes
Specificity
3 %
Genes
100 % |
EBP. Complete sequencing.
By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
EBP
Specificity
100 %
Genes
100 % |
Skeletal dysplasia (NGS panel for 31 genes).
By CGC Genetics (Portugal).
RMRP, SLC26A2, SOX9, TRIP11, NSDHL, TRPV4, P3H1, SBDS, SLC35D1, COL10A1, COL11A1, COL11A2, COL1A2, CRTAP, DDR2, EBP, FGFR3, FLNB, ALPL, HSPG2 , (...)
View the complete list with 9 more genes
Specificity
4 %
Genes
100 % |
You can get up to 46 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET OMIM Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE; THPH2 MYOPATHY, TUBULAR AGGREGATE, 1; TAM1 GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO; MSSE